Skip to content

Clinical trials

Depression, Postpartum trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depression, Postpartum Phase: Not applicable Country / region: United States Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20053
20062
20073
20084
20093
20106
20115
20122
20133
20145
20154
20164
20174
201812
201911
20208
202112
20229
202315
20249
202510
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Recruiting25
Terminated9
Active, not recruiting8
Withdrawn5
Not yet recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University6
Northwestern University6
Children's Hospital of Philadelphia5
University of Pennsylvania5
Women and Infants Hospital of Rhode Island5
University of Colorado, Boulder4
University of Michigan4
University of Rochester4
Weill Medical College of Cornell University4
Johns Hopkins University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depression, Postpartum146
Anxiety Disorders16
Premature Birth12
Major Depressive Disorder5
Stress Disorders, Post-Traumatic5
Obstetric Labor, Premature3
Parasomnias3
Substance-Related Disorders3
Birth Weight2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.